Experience

Bluefields Aceleradora

• Brazil
• Venture Capital and Private Equity Principals
• 1 - 100 Employee

• Startup Mentor (volunteer)

  • Jun 2021 - Present

  A Bluefields acelera startups no início da jornada e grandes organizações que desejam se reinventar através da transformação digital e a cultura de startup. De 2016 a 2020 foram 421 inovadores acelerados e mais de 10Mi captados.A atuação de Startup Mentor consiste em orientar e direcionar os empreendedores no Sparks (programa de validação) e/ou The Big BaM (programa de aceleração). Para isso é necessário domínio do assunto, comunicação clara, flexibilidade e bom relacionamento interpessoal para esclarecer as dúvidas e prepará-los para estruturar sua startup.



Biorigin - Zilor

• Brazil
• Biotechnology Research
• 300 - 400 Employee

• Presidente / CEO

  • Jan 2020 - Dec 2020

  Yeast and cell wall products for Human and Animal nutrition, it is based in Sao Paulo State and present in more than 60+ markets, 4 production units (3 in Brazil and 1 in Louisville/KT-US) and a distribution center in Belgium.  WW responsibility for Sales (Food and Feed), R&D, Marketing and Operations as well as dotted line of the share service center functions such as Finance, HR, IT and Legal. (Total structure of ˜520 employees - publicly informed revenues of approx. $150mi).➢ I drove a turn-around bringing the EBITDA from 2% to ~19%. ➢ Enabled the Go-to-Market strategy for Feed segment through the identification of market unmet needs, listing po-tential new customers, reviewing current portfolio (incl. sub-segments) and sales effort allocation ending up in a detailed 5W2H action plan.➢ Achieved a double-digit growth by implementing the sales funnel concept, reviewing market/customer segmenta-tion and creating a variable compensation for the Business Division.➢ Promoted operational excellence projects that will lead to an impact of approx. $10mi in EBITDA along the next 4 years. ➢ Promoted a project to review the R&D strategy, which included its structure, focus on open innovation and expan-sion of partnerships within universities and other companies in the market segment.



Russell Reynolds Associates

• United States
• Business Consulting and Services
• 700 & Above Employee

• Consultant - Practice Leader Healthcare and Life Science

  • Mar 2018 - May 2019

  Responsible to develop Healthcare and Life Science segment in LatAm➢ Developed and implemented a business strategy to establish the RRA position within the segments such as Pharmaceutical, Medical Devices, Healthcare Services, Diagnostics and Biotechnology companies enabling projects related to executive search and assessment of C-Level. Expanding the business connection and collaboration within offices in USA, Europe and Asia.➢ Led the search of executive positions such as GM LatAm, CEO Brazil, Vice-President Brazil, COO, Commercial Director for LatAm, Commercial Director Brazil, Business Unit Head, CFO. Dealing with companies in the healthcare and life science segment as well as industry, infra-structure and financial services.➢ Assessed executives of Big Pharma and Agribusiness, focusing either in executive development, succession identification during hiring process and in M&A scenarios.



Novozymes

• Denmark
• Biotechnology Research
• 700 & Above Employee

• Regional President LatAm

  • Jan 2015 - Mar 2018

  - Besides being the Chairman of Latin America Regional Leadership Team, I had direct responsibility for Corporate affairs (Public Relations/Public Affairs), Sustainability and Business Development.- Business strategy for Latin America (2015-2020) and support the implementation of a tactical action plan that enabled 10% revenues growth YoY of local accounts- Development of new business platforms and applications in Renewable Chemicals, Beverage (juice and coffee) and Agriculture. Implemented strategies to connect Novozymes to Start-ups network, Industry Associations and Research Centers in Public Universities. Portfolio valuing ~R$150 million;- Development of Legacy jointly with the regional leadership team and spread a new Vision and Values defined by Corporate within the Organization in the region. Strategies and actions jointly with HR to create performance system as well as talent development evaluations and required action plans;- President of the Council at ABBI (Brazilian Industry Biotechnology Association) which has an ongoing effort to promote economic, legal and regulatory framework to boost the bio economy agenda mainly in Brazil. Co-founder Director of UNEM (Brazilian Association for Corn Ethanol - created in September/17), re-structured ABIAM (Brazilian Industry Association for F&B Ingredients Enhancement) and represented Novozymes at ICC Brazil (International Commerce Chamber), AMCHAM (American Chamber) and DANCHAM (Danish Chamber);- Key spokesperson of Novozymes Latin America in regional and global events such as WEF Latin America, Bio World Congress 2016 (panelist), Bio Latin America 2016 (panelist), Ethanol Summit 2015 (panelist), Cleaning Products LatAm 2016 (speaker), CBD 2016 (COP13 – panelist and member of ICC Global commission and Brazilian Foreign Affairs Ministry Commission), Business and Biodiversity Forum 2016 (panelist), etc.



Catalent Pharma Solutions

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Country Manager

  • Oct 2011 - Jul 2014

  - Responsible for all activities in Brazil, leading a matrix structure (Sales, Operations, HR, R&D, Finance) with footprint in Brazil (Sorocaba, Indaiatuba and São Paulo) – Sales team LatAm.- Built the strategic plan for Brazil (2012-2015) and its yearly review. Led the implementation of a tactical action plan reaching a growth in revenues of 80% and bringing the company from negative EBITDA to 14%;- Led negotiations and due diligence process to acquire a local company (Laboratórios Relthy) including negotiations with owners, being afterwards responsible for the integration/consolidation process including cultural alignment, execution of identified synergies and negotiations with health/regulatory authorities related to the M&A;- Led the implementation of actions that doubled employee’s engagement level in less than 2 years (i.e.: reassessment of benefits, implementation of internal hiring process, mechanism/forum to identify employees’ perceptions);- Promoted changes in the local structure aligned with corporate functions to increase efficacy and time-to-market of current portfolio and new businesses. Implemented communication processes to drive the company the objectives, culture & values. Rebuilt operational flows such as budget, quotation, pricing, payments (cash-flow);- Responsible for representing the company in the industry associations such as SINDUSFARMA and AMCHAM (member of the Ethic Committee of the Campinas region) as well as for promoting the company brand and portfolio in trade shows, industry exhibitions and conferences (i.e. FCE Pharma and panelist at Frost & Sullivan - GIL 2012);



Sandoz

• Switzerland
• Pharmaceutical Manufacturing
• 700 & Above Employee

• BD&L & Strategic Planning

  • Jul 2011 - Oct 2011



Boehringer Ingelheim do Brasil

• Business Development & Demand Planning

  • Jul 2010 - Jul 2011

  - Enhancement of forecast concepts, implementation of global tools that reduced variability and connected it to SOPM (Sales & Operations Planning Meeting) as well as the target setting process for product managers and sales managers;- Evaluated and developed a portfolio of products to be launched in the OTC division and initiated the registration process of a extension line for a multi-vitamin (extension line for Pharmaton brand);- Implemented and managed Launch Readiness Process for Rx and OTC division to guarantee that all launch activities were considered to obtain fast time-to-market;



Boehringer Ingelheim

• Germany
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Product Group Manager (Brazil)

  • Jul 2008 - Jun 2010

  - I was responsible for Respiratory line, Women´s Health, Virology and Central Nervous System. Products focused on pneumology, gynecology, psychiatry and virology. Reporting to the VP Marketing, I managed a team composed by 8 people and total revenues of USD 80 million/year.- Led and managed the development, communication and implementation of the strategic and tactical plans for all products in my line (Spiriva, Elodius/Aptivus, Cymbalta and New Product “Flibanserin”)- Responsible for the P&L. Revenues for Spiriva and Cymbalta increased in average 30%/year;- Successfully implemented full switch of a new respiratory device/product for Spiriva in the market;- Responsible for the strategy and target alignment with partner companies (co-promotion with Pfizer and Eli Lilly), being part of the country co-promotion board;- Responsible for communication and relationship with medical associations as well as participation in international and local medical events;Implemented local launch readiness process for new products in Prescription Medicines;

• Manager Business Support Prescription Medicines (Mexico)

  • Oct 2007 - Jun 2008

  - As Business Support Manager at BI Mexico, I was responsible for all activities related to four areas: Marketing Segmentation, Market Research, Business Development and Sales Administration. Reporting to VP Business and Sales Prescription Medicines, managing 42 people (6 direct: including 3 managers). - Led the development and implementation of customer relationship management, customer targeting, definition of work plan for sales reps;- Managed all audits related to market research (IMS, Close-up, Cegedim), with focus on company’s performance to define models for sales force incentives and target setting for all managers in the business division;- Established all information required to be used by the product managers for brand planning (e.g.: market audits, market studies, share of voice, competitors information);- Managed the implementation of projects related to new products, line extensions and changes in the current pipeline, guaranteeing the interface between all involved areas (marketing, supply chain, manufacturing, legal, regulatory affairs and controlling). Led and implemented mechanisms to evaluate new business opportunities for the company through licensees and acquisitions;

• Supply Chain Manager (Mexico)

  • Oct 2005 - Sep 2007

  - Responsible for the following departments: Production Planning, Trade, Distribution, Demand Management and Contract Manufacturing (leading 74 people; 5 managers)- I prepared and implemented the turn-around process in the SCM department. It included activities to optimize processes, reduce costs and improve customers satisfaction by applying Lean/Six-Sigma concepts;- Responsible for development and implementation of the business plan for a new business defined as Contract Manufacturing. Main responsibility was to set a foundation for the new business and to manage all activities for NAFTA region (USA, Canada and Mexico);- Established an adequate product distribution in the internal and external market, fulfilling forecasts and deliveries timeline agreed with customers. Customer service level was improved from 93,1% to 98% and transport costs reduced in average 20%;- Created metrics and reporting tools around the production planning/scheduling processes to improve information visibility and enhance the ability to set, measure and track goals ( e.g.: inventory turn-over increased from 4 to 8 in Mexico);

• Manager Supply Chain Processes (Germany)

  • Feb 2002 - Oct 2005

  - Representing Supply Chain Division in the review of the global operations strategy, working within six modules: Business Process (budget process and its up-dates for operations), MIS – Management Information System, Volumes & Costs, In/Outsourcing, Interface Market & Sales and Assets & Utilization;- Implementation of concepts such as pull, throughput-time, safety stock, EOQ (Economic order quantity) and measurements for the supply chain in two locations (Brazil and Spain);- Successfully implemented a standard production planning tool at global level (WAY/RTS from Wassermann AG), acting jointly with local Supply Chain Manager as project leader. Made a significant contribution towards enhancing processes and guaranteeing a better usage of the concept and the implemented system.

• Logistics Planning Manager

  • Feb 2000 - Jan 2002



Boehringer Ingelheim do Brasil

• Managerial Accounting Manager

  • Jan 1999 - Jan 2000

• Plant Controller

  • Jan 1996 - Dec 1998

• Cost Analyst

  • Jan 1991 - Dec 1995